Literature DB >> 7489346

Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India.

V A Arankalle1, J Jha, M O Favorov, A Chaudhari, H A Fields, K Banerjee.   

Abstract

During 1990, 38 patients with fulminant non-A, non-B hepatitis (NANB) died in Government Medical College Hospital, Aurangabad. Serum samples from these patients were tested for antibodies to hepatitis C virus (anti-HCV) and IgM antibodies to hepatitis E virus (IgM-anti-HEV). All samples were also subjected to polymerase chain reaction (PCR) for the detection of HBV DNA, HCV RNA and HEV RNA. None of the patients had circulating anti-HCV antibodies; three had HCV RNA. Based on anti-HEV-IgM positivity 14 patients (37%) could be diagnosed as suffering from hepatitis E. None was positive for HEV RNA. In the absence of serological markers, HBV DNA was present in three cases. None of the HBV DNA positive patients had anti-delta antibodies. Dual infections (HBV with HEV, and HBV with HCV) were seen in two cases. The aetiology of half of the NANB cases could not be assigned to the known hepatitis viruses using current techniques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489346     DOI: 10.1111/j.1365-2893.1995.tb00028.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  8 in total

Review 1.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

2.  HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt.

Authors:  M Divizia; R Gabrieli; M L Stefanoni; E Renganathan; E El Ghazzawi; O A Kader; F Gamil; G El Sawaf; E El Sherbini; E Saleh; A M Degener; A Noce; L Zaratti; A Modesti; A Panà
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

3.  Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients.

Authors:  Nischay Mishra; Atul M Walimbe; Vidya A Arankalle
Journal:  Virus Genes       Date:  2012-10-10       Impact factor: 2.332

4.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

5.  Analysis of helicase domain mutations in the hepatitis E virus derived from patients with fulminant hepatic failure: effects on enzymatic activities and virus replication.

Authors:  Pradip Devhare; Kavyanjali Sharma; Vaibhav Mhaindarkar; Vidya Arankalle; Kavita Lole
Journal:  Virus Res       Date:  2014-03-11       Impact factor: 3.303

6.  The expression patterns of immune response genes in the Peripheral Blood Mononuclear cells of pregnant women presenting with subclinical or clinical HEV infection are different and trimester-dependent: A whole transcriptome analysis.

Authors:  Ashwini Y Ramdasi; Vidya A Arankalle
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

7.  Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data.

Authors:  Makhmudkhan B Sharapov; Michael O Favorov; Tatiana L Yashina; Matthew S Brown; Gennady G Onischenko; Harold S Margolis; Terence L Chorba
Journal:  BMC Infect Dis       Date:  2009-03-25       Impact factor: 3.090

8.  Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E.

Authors:  Ashwini Y Ramdasi; Ravi P Arya; Vidya A Arankalle
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.